Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1614| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2020-06-21T16:00:33Z | - |
| dc.date.available | 2020-06-21T16:00:33Z | - |
| dc.date.issued | 2020-06-18 | - |
| dc.identifier.uri | https://tn.com.ar/salud/lo-ultimo/coronavirus-cinco-claves-del-suero-hiperinmune-de-caballo-que-se-probara-en-humanos_1083591 | - |
| dc.identifier.uri | http://sgc.anlis.gob.ar/handle/123456789/1614 | - |
| dc.description.abstract | Sería una alternativa de inmunización pasiva más efectiva para atenuar los efectos del COVID-19 a corto y mediano plazo. Esperan la aprobación de la ANMAT. | en_US |
| dc.publisher | TN | en_US |
| dc.subject | COVID19 | en_US |
| dc.subject | Medios de Comunicación | en_US |
| dc.subject | Suero Terapéutico COVID19 | en_US |
| dc.title | Coronavirus: cinco claves del suero hiperinmune de caballo que se probará en humanos | en_US |
| dc.type | Medios | en_US |
| item.openairetype | Medios | - |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | open | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.fulltext | With Fulltext | - |
| Appears in Collections: | ANLIS frente a la epidemia COVID-19 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Coronavirus cinco claves del suero hiperinmune de caballo que será probado en humanos.pdf | 422.39 kB | Adobe PDF |  View/Open |
Page view(s)
63
checked on Apr 19, 2024
Download(s)
4
checked on Apr 19, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.